Knightsbridge Asset Management, LLC Infinity Pharmaceuticals, Inc. Transaction History

Knightsbridge Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.2 $6,232 - $15,262	-12,719 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.85 - $2.4 $10,811 - $30,525	12,719 New	12,719 $14,000
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $460,472 - $600,691	-173,110 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $342,757 - $927,869	173,110 New	173,110 $559,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Knightsbridge Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knightsbridge Asset Management, LLC with notifications on news.